2024 Australasian Forum on PCVBHC

The forum is being delivered through a partnership between three organisations.

About the 2024 Australasian Forum on PCVBHC

The University of Melbourne, Dental Health Services Victoria and Sprink’s Global Centre of Excellence in Person-Centred Value-Based Health Care (PCVBHC) are delighted to invite you to join the PCVBHC Australasian Forum in Melbourne, Australia from 2nd to 3rd September 2024.
Attending the 2024 Australasian Forum on PCVBHC in Melbourne is an opportunity to join a transformative movement that’s shaping the future of health care. This forum offers a unique platform to explore innovative approaches that seek to bring together the personalisation of care and measurement for the individual, with understanding the value of care delivered for individuals, populations and societies and how we do all of this while ensuring the equitable and sustainable allocation of finite resources.

Venue

Melbourne Convention and Exhibition Centre

Theme

Bringing together Person-Centred Health Care, Value-Based Health Care and Health Equity: Person-Centred Value-Based Health Care. The Forum will focus on the following topics:

Who should attend?

The Forum is aimed at the following groups:

Background to PCVBHC

Over the past 30 years health care systems in many parts of the world have focused on creating evidence-based guidelines and aligned to these guidelines, measuring quality based on whether certain processes and structures of care have been followed. This is part of what has been identified as “industrialised and transactional care”.

In 2010, the work of Michael Porter, Elizabeth Teisberg and others highlighted that we might be meeting certain standards of care but this does not mean we are achieving the outcomes that matter to people sustainably. This led to a focus on the concept of value – defining the outcomes that matter, often involving Patient Reported Outcomes (PROs), and relating these to the cost that it takes to achieve them, aiming for the best outcomes at the lowest cost.

However, measuring outcomes, including PROs, still does not enable us to understand what actually matters to a particular person, at a specific point time, in relation to their life and their circumstances. This is the true measure of value.

In 2021, we launched the concept of Person-Centred Value-Based Health Care (PCVBHC), aiming to address the above challenge. PCVBHC emphasises the importance of (i) understanding the values, goals and preferences of individual people, (ii) measuring the extent to which people’s goals have been achieved and preferences respected, (iii) using this data, where necessary, to support the interpretation of standardised datasets, (iv) using user-centred design principles to develop and design services and pathways and (v) using our understanding of people’s values, goals and preferences to inform meso and macro level resource allocation.

Guest Speakers

We are currently in the process of finalising the speakers for the 2024 Australasian Forum on PCVBHC. Stay tuned for updates!

Prof Willem Jan Bos
Professor of Nephrology: Outcomes of Care, Leiden University and Santeon, The Netherlands (Virtual attendance).
Willem Jan Bos is an internist with a specialisation in kidney diseases. He holds a dual role, serving as a faculty member at the Department of Internal Medicine within the Leiden University Medical Centre, where he holds a bestowed chair in “Nephrology: Outcomes of Care.” In addition, he maintains a clinical practice at the St Antoniusziekenhuis in Utrecht/Nieuwegein. Willem Jan is actively engaged in Value-Based Health Care (VBHC) initiatives within both of these health care institutions, as well as in the nephrology project of the Santeon chain of hospitals in the Netherlands. His primary research endeavours are directed towards enhancing health care by implementing value-based principles, with a particular focus on tailoring kidney care to individual patients and optimising kidney care for the elderly population. Willem Jan assumed the role of chair for the recently established Santeon research group dedicated to personalising care. Moreover, he shares the leadership responsibilities of the Linnean Initiative, a national endeavour aimed at promoting VBHC implementation throughout the Netherlands. Additionally, he has chaired the ICHOM working group focusing on chronic kidney disease.
Prof Alf Collins
former NHS England’s Clinical Director, Personalised Care Group (Virtual attendance).

Alf Collins served as the Clinical Director for Personalised Care at NHS England. His policy portfolio encompassed shared decision-making, care planning, self-management support, social prescribing, and health literacy.

With a background as a community consultant in pain management, Alf dedicated many years to this field. Simultaneously, he worked for a decade at the Health Foundation, contributing to applied research and implementation programmes in Person-Centred Care. Alf has extensively researched and published on various aspects of Person-Centred Care, with a specific focus on transforming the relationship between patients and health care professionals.

Recognised for his contributions, Alf holds honorary fellowships from the Royal College of Physicians and the Royal College of General Practitioners. Additionally, he holds a Visiting Professorship in Health care Policy at Coventry University.

Prof Shelley Dolan
Chief Executive, The Royal Melbourne Hospital

Professor Shelley Dolan joined the RMH in August 2023 as Chief Executive. She is a familiar face in the Parkville Precinct, previously serving as the Chief Executive of the Peter MacCallum Cancer Centre.

In her previous roles, Shelley has successfully led large specialist tertiary hospitals in the UK, including as Chief Executive of Kings College Hospital NHS Foundation Trust and Deputy Chief Executive of the Royal Marsden Hospital.

Shelley is a highly respected clinical and research leader with an impressive track record in health care, having successfully led major organisational and cultural change in Victoria and the United Kingdom (UK). Key capabilities include Executive and Non-Executive leadership across national and international bodies, strategy development, delivering excellence in quality and performance, overseeing large capital schemes and innovative research projects that require engagement with a broad range of stakeholders.
Shelley has a PhD in the early diagnosis of sepsis in cancer patients and a master’s degree in advanced practice nursing. She is a Professor (Enterprise) of the Melbourne School of Health Science at the University of Melbourne.

She is Chair of the Western & Central Melbourne Integrated Cancer Service, a Board member of the Victorian Comprehensive Cancer Centre Alliance, the Melbourne Academic Centre for Health, Melbourne Genomics and CRC Participant Director on the Board of Oncology One. In November 2022, the Minister for Health and Aged Care appointed her as a Member of the Cancer Australia Advisory Council.

Elizabeth de Somer
CEO of Medicines Australia.
Elizabeth (Liz) de Somer was appointed as the first female CEO of Medicines Australia in 2018. She is a dedicated advocate and policy expert for the pharmaceutical sector and is well known for her contributions to national policy development. Liz contributes her clinical and industry expertise to a number of expert committees providing advice to Government and brings decades of experience to her role, having worked at the frontline of the medical field including as an intensive care nurse, clinical trials coordinator and clinical research associate. Medicines Australia is the peak body representing research based pharmaceutical companies in Australia, where Liz leads a collaborative team of experts in partnership with industry, government, patient, and the clinical communities, to develop sound policies that support access to innovative medicines for Australian patients.
Prof Jon Emery
Herman Chair of Primary Care Cancer Research General Practice and Primary Care.

Jon Emery is the Herman Professor of Primary Care Cancer Research at the University of Melbourne, and the Victorian Comprehensive Cancer Centre Primary Care Research and Education Lead. He is also Director of the Cancer Australia Primary Care Collaborative Cancer Clinical Trials Group (PC4), and a Visiting Research Fellow at the Department of Public Health and Primary Care, University of Cambridge.

Jon studied medicine at Cambridge and Oxford and obtained his DPhil at Oxford on computer decision support to assess cancer risk in general practice. His research program applies principles of implementation science and focuses on the role of primary care across the cancer continuum including prevention, early diagnosis and survivorship, aiming to improve the integration of health services. He leads a parallel program of cancer research between Melbourne and Cambridge on cancer screening, risk assessment and early diagnosis. He has published over 240 papers and has been a Chief Investigator on research grants and awards totalling over $35 million and an additional GBP16 million. He sits on several national and international advisory committees related to cancer early detection and survivorship, and cancer research.

Cécile Huyghe Garassus
International Developed Markets Innovative Access Director, Pfizer (Virtual attendance).

Cécile Huyghe Garassus has been working at Pfizer for the past six years. She initially joined the French Health and Value team as Portfolio Director in charge of inline assets access and pricing and pipeline strategy. She then joined the Global Access Innovation team to develop strategic partnerships and new contracting models. As an example, over the past three years, she has been advocating for the promotion of value-based financing mechanisms for novel anti-infectives.

Prior to joining Pfizer, Cécile has been a Market Access Director in the medical devices space for more than 13 years allowing her to develop an early understanding of priority topics such as evidence generation leveraging existing databases, digital therapeutics reimbursement and innovative contracting which play a key role in her current position.
Cécile holds a BA in European Studies and two Master’s degrees in Politics, and has attended executive education at Insead.

Prof Russell Gruen
Dean of the College of Health and Medicine at The Australian National University.
Zoe Wainer is the Deputy Secretary for Public Health in the Victorian Government Department of Health. She has previously held roles as the Director of Clinical Governance at Bupa Australia and New Zealand, Chair of the Board of Dental Health Services Victoria and a Director on the Board of the Victorian Responsible Gambling Foundation. Her passion and expertise in public health has driven formal and informal collaborations with the ICHOM, Harvard Business School and The University of Texas at Austin, Dell Medical School in value-based health care across multiple organisations. Zoe also has a continued advocacy focus on the importance of sex differences across health from basic research to health systems implications. Zoe holds a Bachelor of Medicine, Bachelor of Surgery from Flinders University, and has a clinical background in cardiothoracic surgery and thoracic surgical oncology. She has a PhD and a Master of Public Health from The University of Melbourne, is a fellow of the Australasian College of Health Service Management, Associate Fellow of the Royal Australasian College of Medical Administrators and is a graduate of the Australian Institute of Company Directors.
Ben Harris
Director of Policy and Research at Private Health Care Australia.
Ben Harris is the Director Policy and Research at Private Healthcare Australia. An economist by training, Ben has worked for many years in health and social policy roles for government and the not-for-profit sector. He is also the author of a number of policy papers, including Is Medicare Fair? and Australia’s Mental and Physical Health Tracker.
Dr Adam Heathfield
Senior Director, Access Innovation Centre, Pfizer (Virtual attendance).
Jon Emery is the Herman Professor of Primary Care Cancer Research at the University of Melbourne, and the Victorian Comprehensive Cancer Centre Primary Care Research and Education Lead. He is also Director of the Cancer Australia Primary Care Collaborative Cancer Clinical Trials Group (PC4), and a Visiting Research Fellow at the Department of Public Health and Primary Care, University of Cambridge. Jon studied medicine at Cambridge and Oxford and obtained his DPhil at Oxford on computer decision support to assess cancer risk in general practice. His research program applies principles of implementation science and focuses on the role of primary care across the cancer continuum including prevention, early diagnosis and survivorship, aiming to improve the integration of health services. He leads a parallel program of cancer research between Melbourne and Cambridge on cancer screening, risk assessment and early diagnosis. He has published over 240 papers and has been a Chief Investigator on research grants and awards totalling over $35 million and an additional GBP16 million. He sits on several national and international advisory committees related to cancer early detection and survivorship, and cancer research.
Michelle Heijke
International Value Based Healthcare, Erasmus Medical Center Rotterdam, (The Netherlands) (Virtual attendance).
Michelle Heijke is a health economist dedicated to driving Value-Based Healthcare forward globally. Currently based at Erasmus Medical Center Rotterdam, she is actively involved in research on healthcare costs, the education of healthcare professionals, and fostering value-based collaborations for the hospital. Michelle holds a Master’s degree in Health Economics from Erasmus University Rotterdam, where her thesis focused on conducting a cost-utility analysis. Her interests and expertise extend beyond health economics, as evidenced by her Master’s degree in Business Administration, International Management from Vrije Universiteit Amsterdam. She also holds a Bachelor’s degree in Health Sciences. Michelle’s enthusiasm to improve healthcare spans across multiple domains, reflecting her commitment to enhancing patient outcomes and advancing healthcare systems.
Dr Thomas Kelley
CEO, Sprink.
Thomas Kelley is current CEO of Sprink. Prior to this role, between 2018 and 2019, he was the National Clinical Advisor on Value- Based Health Care (VBHC) for the Welsh Government. Between 2013 and 2018 he worked at the International Consortium for Health Outcomes Measurement (ICHOM). He established the London office in 2014 and subsequently led ICHOM’s work in the EMEA region between 2014 and 2017. In 2017 he took overall responsibility for ICHOM’s day-to-day operations across its London and Boston offices. He also had global responsibility for ICHOM’s strategic partnerships. Prior to working at ICHOM he practiced as a physician at Oxford University Hospitals (OUH). He received his BSc and MD from the University of Manchester, UK and MBA from the University of Oxford, UK.
Elizabeth Koff
Managing Director of Telstra Health.

Elizabeth is the Managing Director of Telstra Health. Prior to this, Elizabeth was Secretary for New South Wales (NSW) Health for a six-year term. As Secretary, Elizabeth was responsible for the management of the NSW health system, the largest health system in Australia. Key strategy achievements include the implementation of value-based care across NSW, the progression of E health initiatives and a $2B/year capital infrastructure programme. She oversaw several key initiatives and changes, including the NSW government’s response to the COVID-19 pandemic. She was a key advisor to the NSW crisis cabinet on managing COVID-19 in NSW and the vaccine role out.

Prior to her role as Secretary for NSW Health, Elizabeth was the Deputy Secretary for Strategy and Resources at NSW Health, and Chief Executive of the Sydney Children’s Hospitals Network.

She continues to champion digitalising and integrating health systems to improve patient outcomes, a pursuit she embraced as Secretary for NSW Health.

Prof Linetta Koppert
Associate Professor Surgical Oncology at the Erasmus MC Rotterdam (The Netherlands) (Virtual attendance).

Linetta Koppert is Associate Professor Surgical Oncology at the Erasmus MC Rotterdam. In this university hospital she established in 2014 the multidisciplinary Academic Breast Cancer Center, a centre of excellence for hereditary breast cancer and acknowledged by Orphanet, the Dutch Federation of University Medical Centers and ministry of Public Health. Linetta’s main focus is on breast cancer in young women, BRCA1/2 gene mutation carriers and complex breast cancers. In addition her focus is on thyroid cancer.

Her major research interests are quality of breast cancer surgery, prediction of outcome and Value Based Health Care.

Linetta received her MD in 2001 (cum laude) and her PhD in 2006. In 2009 she was registered as clinical epidemiologist. She has co-authored more than 100 peer-reviewed publications and supervises PhD students. From 2021 she is also occupied at the department of Quality of Healthcare and Patient Care as principal investigator international Value Based Healthcare. She heads the Dutch Health Outcome Observatories (H2O) initiative in which a pan-european data hub is being build for standardized outcome measurement in DM, IBD and cancer including technological requirements in order to empower patients. Linetta is clinical lead of the large digital patient journey project at the Erasmus MC.

Dr Catherine Labinjoh
Realistic Medicine National Clinical Adviser, Scottish Government
Catherine Labinjoh serves as a general cardiologist in NHS Forth Valley and holds the position of National Clinical Advisor for Realistic Medicine with the Scottish Government. In this role, she emphasizes shared decision-making between health care professionals and patients, promoting care tailored to individual needs and preferences. Additionally, she acts as the clinical lead for the Quality Improvement Hub in Forth Valley. Catherine is an elected member of the Council of the Royal College of Physicians of Edinburgh, representing Tayside and Central Scotland. She plays a crucial role in the College’s Equality, Diversity, and Inclusivity Committee and serves as the clinical lead for Enhance, the College’s mentoring programme.
Dr Marleen Kunneman
Assistant Professor of Medicine at Leiden University Medical Center (NL) and Mayo Clinic (USA) (Virtual attendance).
Dr Marleen Kunneman is Assistant Professor of Medicine at Leiden University Medical Center (NL) and Mayo Clinic (USA). She trained as a Clinical Linguist and obtained her PhD in Medical Decision Making. She is a researcher and University teacher on the topic of (how to improve) patient-clinician communication and collaboration to design care plans that fit for each person. She has a special interest in the diverse approaches of collaboration, and in technical vs humanistic approaches of Shared Decision Making, ensuring patient involvement reaches further than just another box to check. Marleen leads the international and interdisciplinary ‘Making care fit Collaborative’ and initiated the ‘Making care fit Manifesto’. Her work is funded by the Royal Netherlands Academy of Arts and Sciences (KNAW) and two personal career awards by the Netherlands Organisation for Health Research and Development and the Dutch Diabetes Foundation. In addition, Marleen is Associate Editor at BMJ Evidence-Based Medicine, where she collaborates with patients to share their care experiences in the ‘Patient Voice’ section.
Susan McKee
CEO, Dental Health Services Victoria, Australia.
Susan Mckee is a Registered Nurse with over 35yrs in the health sector. During this time, she has worked across the healthcare sector with a range of organisations including public, not-for-profit, privately owned and the charitable sector. Her roles have included both clinical and organizational leadership as a Nursing Director, Chief Operating Officer and Chief Executive. Sue is a strategic, values-driven executive, with a proven ability to lead organisations through complex change and challenging external environments. She is committed to leading organisations that provide services that enhance the life of its customers that is true to its purpose and values its people.
Michele Mestrinaro
Vice President and Global Head of Policy, Novartis.
Michele Mestrinaro is the Vice President and Global Head of Policy, where he leads on the company Value-Based Health care agenda. In his current role, Michele is part of the leadership team of a multitude of expert groups on the topic including the Value-Based payments community at the World Economic Forum. Before joining Novartis, Michele worked on Value-Based Health care and health care systems transformation both in the private and public sector in Europe and US through McKinsey and at the World Health Organization. Michele is a physicist by training and an MBA graduate of Harvard Business School.
Dr Susannah Morris
Health Consumer Advocate and Representative.
Susannah Morris is a health consumer advocate and representative specialising in the field of cancer and health technology assessment. She is a social policy expert and former academic by profession who now works to improve the experiences and outcomes of health consumers, with a focus on person-centred, person-led and value-based care. As a social scientist Dr Morris is committed to evidence-based policy and as a health consumer she advocates for, and presents the perspectives of, those who may not have a voice. She is a consumer member of the Pharmaceutical Benefits Advisory Committee and a member of the Health Technology Assessment Consumer Consultative Committee. In these roles she offers a health consumer perspective on and advises regarding consumer engagement with the Australian Government’s health HTA activities. Susannah has recently been appointed as a honorary Senior Lecturer at the University of Melbourne.
Olivia Pantelidis
Executive Director at the Victorian Department of Health | Public Health.

Olivia Pantelidis is a value driven leader with a passion and focus on equity. Over her career Olivia has held various roles in healthcare management and leadership. She is a strategic leader, committed to improving health and care by creating integrated systems that minimise fragmentation and focus on the delivery of safe and equitable care.

Olivia’s current role is as the Executive Director, Strategy and Planning Public Health Division at the Victorian Department of Health where she leads the overall strategy and operations for Victoria’s Local Public Health Units. In her previous roles at the Transport Accident Commission she led the strategic direction towards Value Based Health Care making it a strategic priority for the TACs 2025 strategy and led the Health Care and Trauma partnerships teams and Clinical Advisory Services to ensure clients have access to care.

Dr Helen Rochford-Brennan
Global Dementia Ambassador and Vice Chair of the Irish Dementia Working Group (Virtual attendance).

Helen Rochford-Brennan spent many years working in the tourism and disability sectors and has also devoted tireless years to community activism, working at board level in several organisations. In July 2012, Helen was diagnosed with early onset Alzheimer’s disease. Undeterred, she has since become a prominent figure in dementia advocacy. Currently serving as a Global Dementia Ambassador, Helen holds the role of Vice Chair in the Irish Dementia Working Group, where she previously served as Chair. Additionally, she actively participated in the European Working Group of People with Dementia, assuming the position of Chair, and represents the group on the Board of Alzheimer Europe. Integral to the Monitoring Committee for Ireland’s inaugural National Dementia Strategy, Helen also contributes as a panel member to various advisory groups in both Ireland and Europe. Her advocacy is rooted in a rights-based approach, extending across diverse platforms—from media engagements and international conferences to collaborations with pharmaceutical companies, scientists, clinicians, educators, and participation in research projects. Her advocacy addresses critical areas such as evidence-based diagnosis, palliative care, rural isolation, and the unique challenges posed by living during the Covid lockdown. In recognition of her impactful work on the Rights of People with Dementia, Helen has received several awards, including an Honorary Doctor of Laws degree from the National University of Ireland Galway.

Prof Christobel Saunders
James Stewart Chair of Surgery, University of Melbourne, Australia.

Christobel Saunders is the James Stewart Chair of Surgery, the Head of the Department of Surgery at the University of Melbourne (Royal Melbourne Hospital precinct) and consultant surgeon in the Department of General Surgery at Royal Melbourne Hospital and the Peter MacCallum Cancer Institute.

She is internationally recognised as one of Australia’s most prominent research-orientated cancer surgeons. She has substantially contributed to breast cancer research including clinical trials of new treatments, psychosocial, translational and health services research. In recognition of her sustained career excellence and innovation, she has been publicly acknowledged through numerous awards and honours including Order of Australia 2018, the Uccio Querci della Rovere Award (2018), WA Women’s Hall of Fame Inductee (2018), WA Scientist of the Year (2017) and Cancer Council WA career Achievement Award (2021).

Dr Katharine See
Director of Respiratory Medicine, Northern Health, Australia.

Dr Katharine See is the Chief Health Outcomes Officer and Director of Respiratory Medicine at Northern Health where she leads the Clinical Leadership, Effectiveness and Outcomes team. She is responsible for implementing outcomes collection via digital care pathways, redesigning clinical models of care by enhancing multidisciplinary collaboration, and implementing new technologies all aimed at achieving better outcomes for individuals and better health for populations.

Katharine is passionate about driving change towards Value-Based Health Care and health care reform. She believes digital health will help to deliver the outcomes that matter most of patients and communities.

Jo Szczepanska
Design Practice Lead, cohealth.
Jo Szczepanska is a versatile professional with a background in design, research, and a strong advocate for co-design methodologies. Collaborating with clients and communities, Jo encourages thinking expansively, taking incremental actions, and rapid prototyping. With experience both in Australia and internationally, Jo has been recognized with numerous awards in the realms of sustainability and social impact. She excels in translating generative research insights into outstanding designs. Having accumulated years of expertise in applying co-design across various sectors, Jo holds a Master’s degree in Social Design, specialising in health care experiences. Her focus extends to impact projects with resilient and hard-to-reach communities, employing approaches that enhance accessibility for all involved. In addition to her professional endeavours, Jo shares her knowledge as a lecturer in Design Thinking, Human-Centred Design, and Service Design.
Anne Vogelaar
Project Manager for the Better Together programme - Santeon, The Netherlands (Virtual attendance).

Anne Vogelaar is an experienced project manager with a dedication to health care transformation. Her work and background in the health care sector began as a consultant, where she played a key role in driving the implementation and optimization of Electronic Patient Records (EPDs). Transitioning into the position of a project leader, Anne oversaw numerous implementation projects and utilization streams related to Patient-Reported Outcome Measures (PROMs).

Her commitment is centred on advancing health care practices through collaborative efforts and innovative strategies, with a particular emphasis on personalized, Patient-Centred Value-Based Health Care. Currently serving as a Project Manager for the Better Together programme at Santeon, a collaborative network comprising seven top clinical Dutch hospitals, Anne focuses on Value-Based Health Care (VBHC) through learning and improvement, as well as the personalisation of health care. Within the Better Together programme, Anne and her team aim to enhance healthcare quality by not only considering medical outcomes and costs but also addressing other crucial outcomes important to patients, such as pain or mood after treatment. By doing so our hospitals offer care that adds value to the quality of life of our patients. Since 2015, the programme has successfully implemented VBHC for 15 conditions. Since 2019 Santeon’s VBHC program evolved with the addition of personalising health care. This addition aims to enhance Shared Decision Making supported by outcomes.

Prof Zoe Wainer
Deputy Secretary for Public Health, Victorian Government Department of Health, Australia.
Zoe Wainer is the Deputy Secretary for Public Health in the Victorian Government Department of Health. She has previously held roles as the Director of Clinical Governance at Bupa Australia and New Zealand, Chair of the Board of Dental Health Services Victoria and a Director on the Board of the Victorian Responsible Gambling Foundation. Her passion and expertise in public health has driven formal and informal collaborations with the ICHOM, Harvard Business School and The University of Texas at Austin, Dell Medical School in value-based health care across multiple organisations. Zoe also has a continued advocacy focus on the importance of sex differences across health from basic research to health systems implications. Zoe holds a Bachelor of Medicine, Bachelor of Surgery from Flinders University, and has a clinical background in cardiothoracic surgery and thoracic surgical oncology. She has a PhD and a Master of Public Health from The University of Melbourne, is a fellow of the Australasian College of Health Service Management, Associate Fellow of the Royal Australasian College of Medical Administrators and is a graduate of the Australian Institute of Company Directors.

Programme

We are currently in the process of finalising the speakers for the 2024 Australasian Forum on PCVBHC. Stay tuned for updates!

2nd September 2024. Session 1.

TimeSession
10amWelcome and opening remarks.
10:20amWhat do we mean by Person-Centred Value-Based Health Care (PCVBHC)?

A live mock consultation between a physician and a consumer showing how we typically provide care today.
10:50amReflections on the mock consultation from the speakers and the audience.
11:05amSystems, governments and companies. The next frontier: why it is critical to focus in on values, goals and preferences.
11:40amModerated questions and discussion with all morning speakers.
12:15pmLunch.
TimeSession
1:15pmIntensive Masterclass (1)

How to elicit and use values, goals and preferences in practice.
Intensive Masterclass (2)

How technology can support PCVBHC. Results from the Community of Practice that has been using a PCVBHC tool to capture and aggregate people’s values, goals and preferences.
Intensive Masterclass (3)

How to use values, goals and preferences to shape company pipelines and to measure product effectiveness in both clinical trials and the real world.
Intensive Masterclass (4)

Developing programmes of education and research in PCVBHC.
2:45pmBreak.

Each masterclass lasts 45 minutes and delegates can choose to attend two masterclasses.

TimeSession
3:15pmWhy is all of this important? Coming back to how we started the day – working with people as human beings, as people with lives, aspirations and opinions. We will hear from two people:

• A person living with dementia.

• A person living with multiple sclerosis.
4pm
Putting PCVBHC into practice. We will hear local and international examples of putting PCVBHC into practice.
5pm
Close.
7pmA gala dinner for all attendees. Further details will be released in due course.
TimeSession
10amWelcome and opening remarks.
10amSustainability through personalisation

• Paying for personalised care: the personal health wallets.

• Paying for innovative medicines and technologies: the need to focus on personalisation.

• Creating sustainable systems: personalisation is part of the key.

Questions and discussion.
11amIntensive Masterclass 1

Personalising prevention: tailoring our approaches to individuals.
Intensive Masterclass 2

Personalising services: user centred design.
12pmPersonalisation, value and equity: bringing these together and the role of artificial intelligence.
12:30pmQuestions and discussion.
TimeSession
1pm
Lunch.
2pm
Working in partnership to achieve PCVBHC – from prevention through to diagnosis through to care. This will include representatives from:
• A leading hospital.

• Government.

• A global food company.

• A global biopharmaceutical company.

• A global technology company.
3:30pmWe will invite participants to the stage to share their perspectives on what this means for them.
4pmClosing remarks.
4:30pmClose.

Head of Organising Committee for the 2024 Australsian Forum on PCVBHC.

Dr Andrea Srur
Associate Director, Global Centre of Excellence in PCVBHC, Sprink.
Andrea Srur is a Medical Doctor trained in Chile. Following her training, she completed a MSc in Management and Organisational Innovation (2012) and a MSc in Health Systems and Global Policies (2018), both at Queen Mary University London. She was Head of the Non-Communicable Diseases Department at the Ministry of Health in Chile, working on NCD policies, strengthening the national network. She joined the International Consortium for Health Outcomes Measurement (ICHOM) in London in 2016 as Outcomes, Analytics and Benchmarking Manager. After ICHOM, Andrea was the Programme Manager of the National Children Diabetes Quality Improvement Programme for England and Wales at the Royal College of Paediatrics and Child Health (RCPCH) in London, UK. Since 2022, Andrea is the Associate Director for the Global Centre for Person-Centred Value-Based Health Care, managed by Sprink.

Registration fees

For full-time and part-time students (undergraduates and postgraduates) and consumer advocacy organisations: there is a flat fee of $380 AUD. If you fall into one of these categories, please see below for details on how to get your discount code.

For all other interested attendees, the specific registration fees are outlined in the table below.

RegistrationDatePrice
Governments and government agencies, public hospitals and payers, non-profit organisations, non-governmental organisations (NGOs), university staff, small for-profit companies.*Medium and large for-profit companies.**
Early bird fee
(10% discount on the standard fee). Special rate until 12th May 2024
Until 16 weeks before event.$450 AUD.$900 AUD.
Standard fee.
Special rate until 12th May 2024
From 16 weeks before event.$900 AUD.$1000 AUD.

* small for-profit company (1 to 49 employees).
** medium for-profit company (50 to 249 employees) and large for-profit company (more than 250 employees).

Registration fees – proof of status

If you are eligible for the student or consumer advocate ticket price, please submit one of the following to Andrea Srur (a.srur@sprink.co.uk).

a. Proof of student status

b. Proof of status as a consumer representatives/advocate.

Once the proof of status is received, you will be sent a discount code for you to use when registering for the Forum.

Accommodation

We are currently developing accommodation suggestions. Please stay tuned for further details.

Register now

Currency in AUD
$0.00
Currency in AUD

Please note: if you would rather pay via a purchase order, please contact Andrea Srur (a.srur@sprink.co.uk).

Steering Committee

Prof Willem Jan Bos
Professor of Nephrology: Outcomes of Care, Leiden University and Santeon, The Netherlands.

Willem Jan Bos, MD PhD, is an internist with a specialisation in kidney diseases. He holds a dual role, serving as a faculty member at the Department of Internal Medicine within the Leiden University Medical Center, where he holds a bestowed chair in “Nephrology: Outcomes of Care.” In addition, he maintains a clinical practice at the St Antoniusziekenhuis in Utrecht/Nieuwegein.

Willem Jan is actively engaged in Value-Based Health Care (VBHC) initiatives within both of these health care institutions, as well as in the nephrology project of the Santeon chain of hospitals in the Netherlands. His primary research endeavors are directed towards enhancing health care by implementing value-based principles, with a particular focus on tailoring kidney care to individual patients and optimising kidney care for the elderly population.

Willem Jan assumed the role of chair for the recently established Santeon research group dedicated to personalising care. Moreover, he shares the leadership responsibilities of the Linnean Initiative, a national endeavor aimed at promoting VBHC implementation throughout the Netherlands. Additionally, he has chaired the ICHOM working group focusing on chronic kidney disease.

Dr Thomas Kelley
CEO, Sprink

Thomas Kelley is current CEO of Sprink. Prior to this role, between 2018 and 2019, he was the National Clinical Advisor on Value- Based Health Care (VBHC) for the Welsh Government. Between 2013 and 2018 he worked at the International Consortium for Health Outcomes Measurement (ICHOM). He established the London office in 2014 and subsequently led ICHOM’s work in the EMEA region between 2014 and 2017. In 2017 he took overall responsibility for ICHOM’s day-to-day operations across its London and Boston offices. He also had global responsibility for ICHOM’s strategic partnerships. Prior to working at ICHOM he practiced as a physician at Oxford University Hospitals (OUH). He received his BSc and MD from the University of Manchester, UK and MBA from the University of Oxford, UK.

Ms Susan McKee
CEO, Dental Health Services Victoria, Australia.

Susan Mckee is a Registered Nurse with over 35yrs in the health sector. During this time, she has worked across the healthcare sector with a range of organisations including public, not-for-profit, privately owned and the charitable sector. Her roles have included both clinical and organizational leadership as a Nursing Director, Chief Operating Officer and Chief Executive. Sue is a strategic, values-driven executive, with a proven ability to lead organisations through complex change and challenging external environments. She is committed to leading organisations that provide services that enhance the life of its customers that is true to its purpose and values its people.

Dr Susannah Morris
Health Consumer Advocate and Representative, Australia.
Susannah Morris is a health consumer advocate and representative specialising in the field of cancer and health technology assessment. She is a social policy expert and former academic by profession who now works to improve the experiences and outcomes of health consumers, with a focus on person-centred, person-led and value-based care. As a social scientist Dr Morris is committed to evidence-based policy and as a health consumer she advocates for, and presents the perspectives of, those who may not have a voice. She is a consumer member of the Pharmaceutical Benefits Advisory Committee and a member of the Health Technology Assessment Consumer Consultative Committee. In these roles she offers a health consumer perspective on and advises regarding consumer engagement with the Australian Government’s health HTA activities. Susannah has recently been appointed as a honorary Senior Lecturer at the University of Melbourne.
Prof Christobel Saunders
James Stewart Chair of Surgery, University of Melbourne, Australia.
Christobel Saunders is the James Stewart Chair of Surgery, the Head of the Department of Surgery at the University of Melbourne (Royal Melbourne Hospital precinct) and consultant surgeon in the Department of General Surgery at Royal Melbourne Hospital and the Peter MacCallum Cancer Institute. She is internationally recognised as one of Australia’s most prominent research-orientated cancer surgeons. She has substantially contributed to breast cancer research including clinical trials of new treatments, psychosocial, translational and health services research. In recognition of her sustained career excellence and innovation, she has been publicly acknowledged through numerous awards and honours including Order of Australia 2018, the Uccio Querci della Rovere Award (2018), WA Women’s Hall of Fame Inductee (2018), WA Scientist of the Year (2017) and Cancer Council WA career Achievement Award (2021).
Ms Elizabeth de Somer
CEO, Medicines Australia
Elizabeth (Liz) de Somer was appointed as the first female CEO of Medicines Australia in 2018. She is a dedicated advocate and policy expert for the pharmaceutical sector and is well known for her contributions to national policy development. Liz contributes her clinical and industry expertise to a number of expert committees providing advice to Government and brings decades of experience to her role, having worked at the frontline of the medical field including as an intensive care nurse, clinical trials coordinator and clinical research associate. Medicines Australia is the peak body representing research based pharmaceutical companies in Australia, where Liz leads a collaborative team of experts in partnership with industry, government, patient, and the clinical communities, to develop sound policies that support access to innovative medicines for Australian patients.
Prof Zoe Wainer
Deputy Secretary for Public Health, Victorian Government Department of Health, Australia.
Zoe Wainer is the Deputy Secretary for Public Health in the Victorian Government Department of Health. She has previously held roles as the Director of Clinical Governance at Bupa Australia and New Zealand, Chair of the Board of Dental Health Services Victoria and a Director on the Board of the Victorian Responsible Gambling Foundation. Her passion and expertise in public health has driven formal and informal collaborations with the ICHOM, Harvard Business School and The University of Texas at Austin, Dell Medical School in value-based health care across multiple organisations. Zoe also has a continued advocacy focus on the importance of sex differences across health from basic research to health systems implications. Zoe holds a Bachelor of Medicine, Bachelor of Surgery from Flinders University, and has a clinical background in cardiothoracic surgery and thoracic surgical oncology. She has a PhD and a Master of Public Health from The University of Melbourne, is a fellow of the Australasian College of Health Service Management, Associate Fellow of the Royal Australasian College of Medical Administrators and is a graduate of the Australian Institute of Company Directors.